Impaired CRH and Urocortin Expression and Function in Eutopic Endometrium of Women with Endometriosis

Romina Novembri, Novembri R, Lavínia E. Borges, Lavinia Estrela Borges, Borges LE, Carrarelli P, Patrizia Carrarelli, Ana Luiza Lunardi Rocha, Flavio De Pascalis, de Pascalis F, Florio P, Pasquale Florio, Felice Petraglia
The Journal of clinical endocrinology and metabolism · 2011 · vol. 96(4) , pp. 1145–1150 · doi:10.1210/jc.2010-2263 · PMID:21289256 · W2001848721
article OA: bronze CC0 ⤵ 27 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Women with endometriosis exhibit reduced endometrial expression of CRH and urocortin, impairing their ability to modulate in vitro decidualization of endometrial stromal cells.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

CONTEXT: Women with endometriosis have altered endometrial function. CRH and urocortin (Ucn) are neuropeptides produced by human endometrium and modulate endometrial decidualization. OBJECTIVE: To evaluate endometrial mRNA expression of CRH and Ucn, their role in in vitro decidualization of cultured human endometrial stromal cells (HESCs) in patients with endometriosis, and the role of CRH receptors (CHR-Rs). DESIGN: Obstetrics and Gynecology, University of Siena. PATIENTS: Endometrial specimens were obtained from patients with and without endometriosis. INTERVENTIONS: Endometrial biopsy obtained at both phases of menstrual cycle. In vitro decidualization of HESCs collected from endometriosis or control was done in the presence of CRH, Ucn, or CRH receptor type 1 (CRH-R1, antalarmin) or type 2 (CRH-R2, astressin 2b) antagonists. OUTCOME MEASURES: Endometrial mRNA expression of CRH and Ucn during endometrial cycle; prolactin, CRH-R1, and CRH-R2 mRNA expression during in vitro decidualization. RESULTS: In healthy women CRH and Ucn expression were significantly higher (P < 0.05) in secretory than in proliferative phase; no differences were observed in endometriotic women. During in vitro decidualization, prolactin mRNA expression and release in endometriosis was lower than in control (P < 0.001). CRH and Ucn were able to significantly increase (P < 0.01) prolactin release only in control group; moreover, in this group antalarmin reduced prolactin release (P < 0.01). CRH-R1 mRNA expression increased during in vitro decidualization of HESCs in control (P < 0.01) but not in endometriosis. CONCLUSIONS: Women with endometriosis show an impaired endometrial expression of CRH and Ucn mRNA, and these neuropeptides are no more active in modulating the in vitro decidualization of HESCs, associated with a reduced expression of CRH-R1 mRNA.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Corticotropin-Releasing Hormone Endometriosis Endometrium Urocortins Uterine Diseases Adult Case-Control Studies Cells, Cultured Corticotropin-Releasing Hormone Corticotropin-Releasing Hormone Corticotropin-Releasing Hormone Decidua Decidua Decidua Endometriosis Endometriosis Endometriosis Endometrium Endometrium Female

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (43)

Cited by (28)

Source provenance

europepmc
last seen: 2026-09-26T06:15:21.694264+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:16:48.482574+00:00
License: CC0 · commercial use OK